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1 Background and Development
 of Pollinosis Issues
Pollinosis caused by cedar pollens was first 
reported more than 40 years ago at an academic 
conference held in 1963. The number of cedar 
pollinosis *1 patients has increased ever since, and 
one in every five or six Japanese people is said to 
suffer from the allergy today. The total medical 
expenses directly or indirectly related to cedar 
pollinosis are estimated to reach 286 billion yen 
per year [1].
The mechanism of pollinosis development 
is described in Figure 1. First, cel ls named 
antigen-presenting cells recognize the allergen (a 
protein) contained in cedar pollens and transmit 
its information to type 2 helper (Th2) T cells. 
Then, the Th2 cells order the B lymphocytes 
to produce allergen- specific immunoglobulin 
E (IgE) antibodies. The IgE antibodies bind to 
the surface of the mast cells, which creates an 
allergen-sensitized state. When the same allergen 
enters the body in this state and reacts with the 
IgE antibodies at the mast cell surface, the mast 
cells release chemicals such as histamine and 
leukotriene, which induce allergic symptoms 
such as sneezing, and running and stuffy noses. 
Any one of these steps can be blocked in the 
measures against pollinosis.
Neither sensitization nor allergic reactions 
would occur in the absence of the allergen, so 
the fundamental cause of cedar pollinosis is cedar 
pollen. As shown in Figure 2, Japan's forest cover 
is 25.12 million ha, corresponding to about 70% 
of the total land area (37.79 million ha). Planted 
forests cover 10.36 million ha, which is about 
40% of the forest cover. The total area of planted 
cedar forests is 4.52 million ha, accounting for 
18% and 44% of the forest cover and the planted 
forest area, respectively, while the total area 
of planted cypress forests is 2.57 million ha, 
accounting for 10% and 25% of the forest cover 
and the planted forest area, respectively. Thus, 
planted forests of cedar and cypress, together, 
occupy 28% and 19% of the forest cover and the 
Figure 1 : Diagram of the mechanism of pollinosis development
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total land area, respectively. Since most natural 
forests also comprise broadleaf trees, the actual 
area occupied by these conifers in natural forests 
is unknown. Nevertheless, natural forests are 
also included in addition to the planted forests 
for the actual calculations. The area of cedar 
plantation rapidly expanded after World War II 
and remained at a high level until around 1970. 
As a result, the majority of the cedar trees are 
currently aged from 30 -50 years[3], as shown in 
Figure 3. Cedars increase their pollen production 
at around 25 years and, once they reach 30 years, 
they constantly produce a large amount of pollen 
for several decades. The expansion of the area of 
cedar forests aged over 30 years coincides with 
the increase in the number of cedar pollinosis 
patients since 1975[3]. Apparently, the most 
important factors responsible for the increase of 
cedar pollinosis are the increased pollen counts 
in the environment associated with the expansion 
of cedar and cypress forests, and the resulting 
increase in the strength and frequency of pollen 
exposure. Since cedars are expected to live 
almost 100 years, if the cedar forests are left as 
they are, we cannot expect any decrease in cedar 
pollen levels for decades.
The increase of pollinosis can be viewed as 
a part of the worldwide increase in allergic 
diseases which potentially involve various factors 
including changes in lifestyle, improvements 
i n  s a n i t a r y  cond i t ions ,  cha nges  i n  d ie t ,  
environmental pollution. The involvement of air 
pollution in pollinosis has been suspected since a 
higher prevalence was reported among residents 
along Nikko Kaido, a busy road, than among 
those living in areas distant from the street, but 
potentially inhaling a large amount of pollen[4]. 
Moreover, interesting results were achieved 
from an animal test, which demonstrated that 
diesel emissions could exacerbate al lergic 
reactions. Although results from epidemiological 
studies lack consistency, a survey conducted 
on elementary students by the Ministry of the 
Environment demonstrated that the prevalence of 
cedar-specific IgE antibody and pollinosis were 
related not only to the pollen count, but also to 
Figure 2 : Proportion of planted cedar/ cypress forests in 
 forest cover
Source: Reference [2]
Figure 3 : Areas of planted cedar/ cypress forests by forest age class
Source: Reference [2]
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the air pollutant level in the residential area[5]. 
Many toxicological findings also suggest the 
involvement of diesel emissions.
2 Past Efforts Concerning
 Pollinosis Research
Ever since the increase in the cedar pollen 
count in the environment and the increase in the 
number of pollinosis patients were first noticed in 
the 1970s, several studies have been conducted by 
organizations, including the Ministry of Health, 
Labour and Welfare (MHLW). In 1975, a study on 
the airborne pollen count was started utilizing 
the network of national hospitals and sanitariums 
and was funded by a MHLW Health Science 
Research Grant. After that, pollinosis research 
groups, mainly financed by the MHLW Health 
Science Research Grant, were organized over 
several terms. These groups, mainly consisting 
of otolaryngology and respiratory clinicians, 
conducted not only epidemiological studies on 
pollinosis, or clinical and therapeutic research, 
but also palynological studies such as an airborne 
pollen survey[6].
Meanwhile, the Forestry Agency approached 
the cedar pollen issue from a forestry standpoint 
and started the Cedar Pollen Survey Project in 
1987, which involved the investigation of cedar 
pollen sources in metropolitan areas, surveys on 
pollen production in cedar forests and related 
factors, and surveys on cedar pollen dispersion[7].
Through these ef for ts of the indiv idua l 
ministries and agencies, a committee comprising 
representatives from relevant ministries and 
agencies was established in 1990 to investigate 
and d i scuss  the cur rent  s t atus of  pol len 
dispersion and pollinosis as well as the cause of 
and measures to combat the allergy. From 1997, 
“Comprehensive Studies towards Overcoming 
Cedar Pol l inosis”, f inanced by the Special 
Coordination Funds for Promoting Science and 
Technology, was conducted over two terms 
for a total of six years with the cooperation of 
the related ministries and agencies at the time 
(Ministry of Education, Science, Sports and 
Culture, Ministry of Health and Welfare, Forestry 
Agency, Japan Meteorological Agency, and 
Environmental Agency)[1].
Apart from the governmental agencies, local 
governments have also addressed the issue 
using their own approach. In 1983, the Tokyo 
Metropolitan Government launched a study 
group on measures against pollinosis and started 
cedar pollen count measurements and patient 
surveys, which have continued ever since. 
Other prefectures have cooperated with the 
local medical associations, universities, etc. and 
played pioneering roles in the establishment of 
systems for measuring pollen counts or providing 
information to the residents. In Japan, cedar 
pollens have been manually counted using a 
traditional method called the Durham method. 
For many years, the method was supported by 
doctors, researchers from various fields, and 
citizen volunteers. Today, an NPO group, Pollen 
Information Association, plays the central role.
3 Current Status of Measures
 Against Pollinosis
In February 2004, the Council for Science 
and Technology Policy established a Research 
Committee on Measures Against Pol l inosis 
comprising executives from relevant ministries 
and agencies, and experts on pol l inosis to 
promote s tud ies  on measu res  to  combat  
p o l l i n o s i s .  T h e  co m m i t t e e  a n n o u n c e d  
“Governmental Efforts Concerning Pollinosis 
for This Term”[8] and suggested some specific 
policies shown in Table 1.
Among such efforts, those directly related to 
the measures against pollinosis can be broadly 
classified into pollen source control, exposure 
reduction, and prevention and treatment.
(1) Pollen source control
Control of cedar and cypress forests serving as 
pollen sources is the most basic countermeasure 
against pollinosis. The pollen source control 
policies currently promoted by the Ministry of 
Agriculture, Forestry, and Fisheries (MAFF) are (i) 
development and spread of low-pollen varieties 
etc., and (i i) logging and thinning of trees 
producing many male flowers. The development 
of low-pollen cedar varieties producing less 
than 1% of normal pollen production has been 
somewhat successful, supplying about 240 
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thousand low-pollen trees over the past five years 
and potentially supplying about 600 thousand 
over the next five years[3].
(2) Reduction and avoidance of exposure
This class of policies involves the reduction 
or avoidance of exposure to cedar pollens at 
any of the stages including pollen production, 
pollen dispersion in the environment, and human 
exposure to pollens.
Ced a r  pol len  d i sper s ion  i s  a  s ea sona l  
phenomenon, so it is important to predict the 
beginning and end of pollen dispersion. It is also 
important to predict the total pollen count that 
greatly varies from year to year. Since anti-allergic 
drugs are commonly used as the initial drugs 
administered about two weeks before the pollen 
dispersion begins, an increase in prediction 
accuracy at the beginning of pollen dispersion 
is critical to appropriate treatment, as well as to 
reducing medical costs and the patient burden.
Another means for reducing exposure to 
pollens is to reduce opportunities for contact 
with pollen or to avoid activities that would 
result in contact with pollen. Pollen forecasts 
for today and tomorrow, provided as a part of 
the weather forecast, are critical to the selection 
of one’s activities to avoid pollen exposure. A 
forecast system for a shorter term, e.g. an hourly 
forecast, would require pollen production data 
and meteorological data with the equivalent 
temporal resolution. In fiscal year 2002, the 
Ministry of the Environment placed automatic 
pollen counters in urban and mountain areas 
in the Kanto, Kansai, and Chubu regions and 
started to collect and provide hourly data on 
pollen dispersion. The ministry will eventually 
place the pollen counters all around the country. 
Cedar pollens are believed to travel several dozen 
kilometers, so a pollen dispersion model that 
covers a wide area is needed. For example, the 
establishment of a pollen prediction model for 
Tokyo would require data collected from the 
entire Kanto region.
(3) Prevention and treatment
Pollinosis can be prevented or treated by 
blocking any of the several stages shown in Figure 
1. The most fundamental form of prevention is to 
avoid contact with pollen. Meanwhile, another 
preventive approach is to suppress the allergic 
reactions developed after contact with pollen in 
a sensitized subject, in which pollen-specific IgE 
antibodies are produced and bound to the surface 
of the mast cells. The latter involves suppression 
of the allergic symptoms in patients who have 
already developed pollinosis, so it is difficult to 
draw a clear distinction between prevention and 
treatment.
Currently, the Ministry of Education, Culture, 
Spor t s ,  Sc ience and Tech nolog y ( ME XT ) 
and MHLW are focusing on research and 
development of cedar pollen CpG vaccines 
and subl ingual desensit izat ion (Figure 4). 
Meanwhile, MAFF is promoting the development 
of pollinosis - relieving rice (Figure 5). These 
Table 1 : Efforts concerning measures against pollinosis
Program Item Relevant ministries and agencies
Understanding 
of current status 
regarding pollen
and pollinosis
(i) Prediction of pollen production MAFF
(ii) Weather forecast, etc. Japan Meteorological Agency
(iii) Forecast and monitoring of the pollen count Ministry of the Environment
Identification of the 
cause of pollinosis
(i) Identification of the disease mechanism MEXT/MHLW
(ii)  Identification of the relationship between pollinosis and 
general environment
Ministry of the Environment
(iii) Establishment of a research base MEXT/MHLW
Measures against 
pollinosis
(i)  Development and spread of preventive and therapeutic methods MEXT/MHLW
(ii) Development and spread of low-pollen varieties etc. MAFF
(iii)  Promotion of logging and thinning of trees producing many 
male flowers
MAFF
(iv) Securing appropriate medical service for pollinosis MHLW
(v)  Provision of information concerning pollen and pollinosis MHLW/MAFF/Ministry of the Environment
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Figure 4 : Road map for development of therapeutic methods promoted by MEXT and MHLW
Figure 5 : Road map for the development of pollinosis-relieving rice promoted by MAFF
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prevention and treatment methods are extensions 
of a therapy cal led desensitization therapy 
and can be classified as curative treatments, 
which can be distinguished from symptomatic 
treatments based on anti - allergic drugs. Such 
curat ive t reatments seem to be the most 
promising measures against pollinosis.
Desensitization therapy is an allergen-specific 
immunotherapy involving the routine injection 
of cedar pollen extracts over two or three years, 
starting with low doses and acclimatizing the 
body to the allergen to suppress the allergic 
symptoms. This method has been commonly 
used in the U.S. and European countries but has 
been rather rare Japan, due to some disadvantages 
such as the need for several hospital visits over 
long periods and a low but non-negligible risk 
of al lergy shock. Among the stages for the 
establishment of sensitization shown in Figure 1, 
the immunotherapy under study suppresses the 
action of Th2 cells or B lymphocytes to reduce 
pollen-specific IgE antibody production.
The use of cedar pollen-specific CpG vaccines 
involves suppression of the cedar - speci f ic 
Th2 cells by administering the major protein 
components of the cedar pollen allergen, Cry j 1 
and Cry j 2, bound to bacterial or microbial DNA 
fragments (unmethylated CpG motifs) known 
to have strong immunostimulatory activities. 
In the U.S., their counterpar ts contain ing 
ragweed pollen allergens instead of cedar pollen 
allergens, have been tested in clinical trials and 
demonstrated to be effective against ragweed 
pollinosis. The efficacy of cedar pollen CpG 
vaccines has already been confirmed in mice, and 
preparations for their clinical trials are currently 
in progress. Once their efficacy and safety are 
confirmed through the clinical trials, the vaccines 
will be put into practical use two or three years 
after the beginning of the clinical trials.
Unlike conventional desensitization through 
injection, sublingual desensitization achieves 
desensitization by dropping pollen extract under 
the tongue (or, generally, by placing a piece of 
bread impregnated with the pollen extract under 
the tongue for about two minutes). The method 
has already been approved in Europe, and a large 
amount of data showing its efficacy is available.
The pollinosis -relieving rice is rice that has 
been genetical ly modif ied to accumulate a 
peptide considered to prevent cedar pollinosis 
in the endosperm. The peptide contains a 
peptide (7Crp) consisting of seven linked major 
antigenic determinants (T-cell epitopes) of cedar 
allergens recognized by human T cells among 
the known T-cell epitopes. The gene encoding 
the peptide is further linked to some genes 
required for gene transfer. The rice containing 
the pollinosis -preventing peptide is approved 
for use etc. in isolated fields under the Law 
Concerning the Conservation and Sustainable Use 
of Biological Diversity through Regulations on 
the Use of Living Modified Organisms (Cartagena 
Law). In the road map provided by MAFF, the rice 
will be first subjected to environmental and food 
safety assessment, followed by confirmation of its 
efficacy in humans, before it is put into practical 
use.
4 Future Directions of Measures
 Against Cedar Pollinosis
4-1 More effective control of pollen sources
 and evaluation of its validity
For more effective control of pollen sources, 
closer linkages must be established between 
pollen source control and the development of 
a pollen forecast system promoted by MAFF/ 
Forest r y Agency and the Min ist r y of  the 
Environment/ Japan Meteorological Agency, 
respectively. A map illustrating the degree of 
contribution of cedar/ cypress forests in Japan to 
the pollen exposure of population groups needs 
to be produced, and the cedar/ cypress forests 
must be prioritized as targets for pollen source 
control. Moreover, the cost and the manpower 
required for the control must be estimated, and a 
road map for the entire policy must be produced.
Under existing conditions, it is difficult to 
predict the decrease in the sensitization rate 
from the predicted decrease in the pollen count 
as a result of pollen source control conducted in 
cedar/ cypress forests in a certain area. Thus, it is 
essential to promote studies on the relationship 
between pollen exposure and allergic reactions 
to pollens.
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(1) Cost and manpower required for
 pollen source control
Application of the pol len source control 
promoted by the MAFF/ Forestry Agency to the 
vast area of cedar/ cypress forests would require 
a huge commitment in manpower and money, but 
neither has been clearly estimated. In the budget 
for the fiscal year 2005, 250 billion yen was 
allocated for the development and maintenance 
of 6.4 million ha of forest as a part of the global 
warming policy. The forest development cost 
related to cedar pollinosis control would perhaps 
be equivalent to this, or even higher. Meanwhile, 
forestry workers in our country have become 
older and decreased in number to about one-third 
of that 30 years ago (Figure 6). It is unclear 
whether there would be enough manpower to 
practice forest development and maintenance as a 
part of cedar pollen source control.
(2) Prioritization of target areas for
 control based on estimation
Although the existing trees should be replaced 
with those producing less or no pollen, and trees 
producing many male flowers should be logged 
or thinned, it is unrealistic to work on all of the 
vast cedar/ cypress forests at once. Thus, the 
first thing to do is an individual estimation of the 
degree of contribution of cedar/ cypress forests to 
the pollen exposure of population groups in each 
area of the country, followed by prioritization 
of the forests. For instance, it is necessary to 
identify cedar/ cypress forests that are making 
the largest contribution to the heavily populated 
metropolitan areas. The determination of the 
priority should be followed by an estimation 
of the funds and manpower required for the 
policy and the establishment of a road map for 
the entire policy. Accomplishment of these tasks 
would require the establishment of a cedar pollen 
forecast model including a system for predicting 
cedar pol len production and dispersion, a 
system for predicting the airborne pollen count 
described in 4-1(3), and a weather observation/ 
forecast system serving as its basis. In addition, 
the prioritization should be performed by taking 
into account the important functions of the 
forests from the standpoints of land conservation 
and prevention of global warming, such as their 
roles as CO2 sinks and watershed protection 
forests.
(3) Accumulation of observation data and
 the improvement of accuracy
Since cedar pollens are believed to travel 
several dozen kilometers, a pollen forecast model 
that covers a wide area needs to be established. 
Moreover, considering the flow rate of pollens 
in the atmosphere, the observation data should 
be collected on an hourly basis. Unfortunately, 
the currently available observation data on 
Figure 6 : Transition of the number of forestry workers and composition ratio according to their age
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spatial and temporal pollen distribution are 
inadequate. A i rborne pol len counts were 
conventionally measured through an approach 
called the Durham method, in which pollens 
deposited on a slide glass are stained and counted 
under an optical microscope. In the Durham 
method, observations are usually made on a daily 
basis, making it difficult to establish an hourly 
prediction system based on the observation 
data obtained through this method. Currently, 
real - time data on pollen production in cedar 
forests serving as cedar pollen sources are 
virtually unavailable. The monitoring system 
developed by the Ministry of the Environment has 
only a limited number of monitoring sites, and a 
fundamental discussion on the number and the 
location of monitoring sites would be required 
to increase the accuracy of the pollen forecast 
system. Furthermore, since the existing automatic 
pol len counters are not designed as cedar 
pollen-specific counters but are merely particle 
counters that count any particles of the same size 
as cedar pollens, errors may be observed under 
certain conditions. Thus, the system and accuracy 
of the pollen counter itself needs to be improved.
Currently, the prediction of the total pollen 
count for the year is performed based on the 
f lower setting of the male cedar f lowers and 
is available before the cedar pollen season, i.e. 
around November or December. Cedar f lower 
buds are formed in the summer, and their 
formation is affected by weather conditions in the 
summer. Based on this fact, a statistical prediction 
system based on summer temperature etc. had 
been proposed. However, since other factors are 
also involved in flower bud formation, predictions 
based only on the summer temperature or other 
weather conditions produced some errors. 
Consequently, the total pollen count has been 
predicted based on the observation of the male 
f lowers in autumn when they show a marked 
growth and prediction accuracy has increased in 
recent years.
On the other hand, predictions of the onset 
and end of pollen dispersion are not sufficiently 
accurate. In particular, the onset is linked to the 
initiation of drug administration, so it should 
be predicted with an accuracy of a few days. 
Cedar male flowers stop growing in autumn and 
enter dormancy. The onset of pollen dispersion 
is predicted by analyzing the meteorological 
factors involved in dormancy breaking. However, 
the mechanism of dormancy breaking is not 
sufficiently understood, and fundamental studies 
are needed to increase prediction accuracy.
(4)  Establishment of a method for evaluating
 the impact of measures
Many problems are left unsolved concerning 
the evaluation of the impact of the measures. As 
mentioned earlier, the development of pollinosis 
comprises two stages, i.e. sensitization and 
symptom development, but the dose - effect 
relationship has not been clearly established for 
either of the steps. In particular, there are no 
collective data on the relationship between the 
degree of pollen exposure and the sensitization 
rate in certain population groups with a genetic 
predisposition. Thus, it is difficult to predict 
sensitization rate reduction from the predicted 
reduction in the pollen count resulting from 
pollen source control in cedar/ cypress forests. 
Meanwhile, there are some findings on the 
degree of pollen exposure (pollen count) during 
the pollen dispersion season that triggers the 
allergic symptoms in a person already developing 
pollinosis. These findings have been used for 
ranking cedar pollen dispersion in the forecast. 
Although such ranking is not reliable enough to 
accurately evaluate the impact of measures, at 
least for the time being, there is no choice but 
to use the development of allergic symptoms 
as a measure of the impact. Elucidation of the 
dose-effect relationship between pollen exposure 
and its outcome requires reinforcement of the 
pollen monitoring network and continuation 
of epidemiological surveys on young people 
at ages that are critical to the establishment of 
sensitization.
4-2 Solutions for problems concerning
 prevention and treatment
The results of high priority basic research 
on  t he  new prevent ive  a nd  t her apeut ic  
methods currently in progress, such as vaccine 
development and sublingual immunotherapy, 
suggest that these methods have a high potential 
for practical application. In the future, they need 
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to be tested in clinical trials to be approved as 
pharmaceutical drugs, which would require 
some research support. Joint developments with 
pharmaceutical companies etc. would be essential 
for their practical application, and problems that 
may arise during such joint developments should 
be clarified in advance.
(1) Support for research and clinical trials
In order to put the currently developed 
preventive and therapeutic methods into practice 
as soon as possible, it is essential to provide both 
research support for basic studies on the immune 
system and allergies, and practical support for 
clinical trials. Research performed for developing 
and commercial izing promising diagnostic, 
therapeutic, or preventive methods based on 
the results achieved through basic studies in 
the life sciences and returning the outcome to 
the patients is called translational research. The 
development of cedar pollen vaccines is a good 
example of translational research. In cancer 
research, MEXT started the “Cancer Translational 
Research Project”[11] in fiscal year 2004 (Figure 
7). This project targets phase I and the first half 
of phase II of clinical trials, and the Foundation 
for  B iomed ica l  Resea rch and In novat ion 
(Translational Research Informatics Center) 
provides some support for the preparation 
of clinical study protocols, management, and 
statistical analysis of clinical data, etc. Meanwhile, 
concerning the second half of phase II and phase 
III clinical trials, the basic policies of the project 
state “(the target research) shall be feasible, e.g. 
phases II and III of clinical trials shall be taken 
over by companies etc.”, which assumes that 
companies such as pharmaceutical companies, 
that would benefit from the practical application, 
will bear the costs of clinical trials, and work on 
approval procedures. The development of cedar 
pollen vaccines would require similar support.
In a review[12] summarizing 100 reports on 
sublingual immunotherapy, Cox claimed that, 
although the method was effective in relieving 
symptoms and reducing the doses of  the 
therapeutic drugs, there were some questions 
about the effective dose and schedule, timing, 
mode of action, and safety in hypersensitive 
groups. More clinical data should be gathered to 
optimize the dose and administration method of 
the allergen, and the efficacy and safety of cedar 
pollen allergen extract should be evaluated as 
soon as possible to achieve early approval of the 
vaccine.
(2) Promotion of vaccine development etc.
The results of basic research on vaccines 
preventing the development of cedar pollinosis, 
Figure 7 :  Cancer Translational Research Project 
Source: Reference [11]
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such as CpG vaccines, suggest that these 
vaccines have a high potential for practical 
application. However, drug development is often 
associated with many problems that have led to 
the cessation of clinical trials and the failure of 
many drugs to reach commercialization in the 
past. The development of such vaccines would 
also be confronted by many problems that need 
to be solved. As can be seen from the example 
of the Cancer Translational Research Project, it 
is beyond the capacity of individual researchers 
or research institutions to complete all phases 
of the clinical tr ials, achieve governmental 
approval, and reach commercialization. Yet, the 
government can only make a limited commitment 
to the implementation of clinical trials. This 
problem can only be solved through joint 
development with pharmaceutical companies etc. 
The cooperation of pharmaceutical companies 
is also vital for the development of sublingual 
desensitization, as pol len extracts that are 
different from those approved for injection use 
would need to be newly approved under the 
Pharmaceutical Affairs Law.
(3) Safety confirmation of
 pollinosis-relieving rice
Since pollinosis -relieving rice is based on an 
innovative idea, a highly advanced assessment 
on procedures of safety and efficacy evaluation 
is required. The rice would also be confronted 
by many problems. Following the procedures 
for environmental assessment of genetically 
modif ied crops speci f ied in the Cartagena 
L aw,  t he  nex t  t a sk  concer n i ng  t he  r ice  
containing the pollinosis -preventing peptide 
is to achieve approval for its cultivation in 
open fields[13]. Regarding the assessment of its 
safety as food, the Food Safety Commission has 
established standards for safety assessments of 
genetically modified foods[14]. Thus, if the rice 
containing the pollinosis -preventing peptide 
is viewed only as a genetically modified food, 
well-defined procedures are already in place for 
its environmental and food safety evaluation. 
However, for the practical application of peptide 
vaccines or other immunotherapy methods 
using 7Crp itself, their efficacy and safety as 
pharmaceutical products must be assessed under 
the Pharmaceutical Affairs Law. Consequently, if 
the rice is viewed as a pharmaceutical product, 
it must undergo all phases of the clinical trials 
shown in Figure 7. Moreover, it would have to 
overcome the negative views of consumers about 
genetically modified foods in general.
5 Conclusion
The present article focused on cedar/ cypress 
pol l inosis and provided an outlook of the 
prospects for measures to combat this problem, 
which is of national concern. A substantially high 
incidence is reported for other types of pollinosis 
caused by, for example, Gramineae pollens, 
although conditions for their development are 
not fully understood due to the limited range 
of pollen dispersion, etc. The involvement of 
environmental pollution such as air pollution in 
pollinosis is often highlighted, but environmental 
pollution seems to be involved in al l other 
allergic conditions as well. A drastic increase of 
allergic diseases has been observed worldwide, 
although the increase in cedar pollinosis seems 
to have a history that is unique to our country. 
Nevertheless, before starting individual research, 
f irst we must clearly define the position of 
the measures against cedar pollinosis in the 
prevention and treatment of allergic conditions in 
general.
Glossary
*1 Cedar pollinosis
 Other wise  k nown as  ceda r/  cypress  
pollinosis, as most cedar pollinosis patients 
develop allergic symptoms in response to 
cypress pollens as well as cedar pollens. 
Unless there is a need, this article does not 
distinguish between cedar pollinosis and 
cypress pollinosis.
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